Patient involvement
Lymphoma, Leukemia, Cancer
LYMPHOMA, EVENTS, LEUKEMIA, CANCER
In a pre-study phase patient’s priorities and information preferences were assessed to optimize the patient trial information in cooperation with the Department of Self-help Research of the Comprehensive Cancer Center Freiburg (CCCF). In addition, patients’ representatives of a national patient advocacy organisation (German Leukemia and Lymphoma Aid DLH) were involved to support us in improving the informed consent material of the trial. As a result, a checklist for the informed consent discussion with the patient was developed to support the study physicians. At regular intervals patients and their families will be informed about the process of the trial in patient information events. Our positive experience with the participation of patients in the pre-study phase encouraged us to involve patients’ representatives (German Leukemia and Lymphoma Aid, DLH) throughout the whole period of the clinical trial in the data monitoring committee (DMC).